UH Seidman Cancer Center at ASTRO 2026
Search ASTRO to Learn More About UH Seidman Cancer Center Presenters
ASTRO Annual Meeting
This page highlights posters and presentations led by UH Seidman Cancer Center faculty and collaborators across a range of cancer specialties, reflecting ongoing efforts to advance cancer care through clinical research, translational science, and multidisciplinary collaboration. Explore the list below to see the breadth of work being shared on a national stage.
Serageldin Attia, MD
Tuesday, September 29 | 2:15 p.m. – 3:30 p.m. | Poster Hall – Exhibit Hall A | Screen 9
- Poster Session: PQA 07 - Head and Neck Cancer, Lung Cancer/Thoracic Malignancies, and Nursing and Supportive Care
- Presentation: 3425 - Safety and Dose-Limiting Toxicities of Concurrent Radiotherapy with Tarlatamab in Relapsed/Refractory Small Cell Lung Cancer: A Single Institution Retrospective Analysis
Jennifer Dorth, MD
Sunday, September 27 | 5:02 p.m. – 5:17 p.m. | Room 107
- Education Session: EDU 05 - Radiotherapy Treatment Planning for Anal Cancer: Personalized Radiation and Modern Techniques
- Presentation: Radiation Planning and Treatment Strategies for Early Stage Anal Cancer - Evidence Based Suggestions
Beatriz Guevara, MS
Monday, September 28 | 3:00 p.m. – 4:00 p.m. | Poster Hall – Exhibit Hall A | Screen 6
- Poster Session: PQA 04 - Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Functional Radiation Medicine, Hematologic Malignancies, Palliative Care, and International/Global Oncology
- Presentation: 2741 - Development and Validation of an Automated Workflow for Re-Irradiation Constraint Generation In Radiation Therapy
Lauren Henke, MD
Saturday, September 26 | 11:25 a.m. – 11:50 a.m. | Room 204
- Medical Physics Workshop 01 - Physics Insights for Advanced Clinical Practice: Adaptive, Re-irradiation, AI and Trials
- Presentation: Session 2 - Adaptive Therapy Part I: Clinical Rationale for ART
Saturday, September 26 | 12:15 p.m. – 12:25 p.m. | Room 204
- Medical Physics Workshop 01 - Physics Insights for Advanced Clinical Practice: Adaptive, Re-irradiation, AI and Trials
- Presentation: Q&A
Saturday, September 26 | Time TBD | Location TBD
- Varian User Meeting
Tuesday, September 29 | 2:40 p.m. – 3:00 p.m. | Room 156
- Session: International 06 - CT-Guided, MRI-Guided, or Offline Adaptive Radiation Therapy? A Structured, Case-Based Debate on Value, Efficiency and Use across Global Resource Settings
- Presentation: CT-Guided Online Adaptive Radiation Therapy: Case-Based Evaluation of Workflow Efficiency, Scalability, and Implementation Across Resource Settings
Angela Jia, MD, PhD
Tuesday, September 29 | 3:55 p.m. – 4:05 p.m. | Room 210
- Session: SS 36 - Predicting Benefit and Toxicity: Biomarkers in Prostate Radiotherapy
- Presentation: 312 - Genomic Stratification of Benefit from Short-Term Androgen Deprivation with Dose-Escalated Radiotherapy in Intermediate-Risk Prostate Cancer: An Ancillary Study of NRG/RTOG 0815
Rojano Kashani, PhD, DABR, FAPPM
Tuesday, September 29 | 3:17 p.m. – 3:32 p.m. | Room 157
- Education Session: EDU 04 - Breathing Motion Management in 2026: Recommendations from AAPM Task Group 324, Updated Guidance on the Management of Respiratory Motion in Radiation Oncology
- Presentation: Imaging and Positioning for Lung and Upper Abdominal Tumors
Joan Lee, MD
Tuesday, September 29 | 2:15 p.m. – 3:30 p.m. | Poster Hall – Exhibit Hall A | Screen 9
- Poster Session: PQA 06 - Genitourinary Cancer, Gynecological Cancer, and Health Care Access and Engagement
- Presentation: 3302 - Characterizing the Consult to CT-Simulation Interval in the Setting of Screening Colonoscopy Prior to Prostate Radiotherapy in a VA Patient Population
Qing Li, MD, PhD
Tuesday, September 29 | 2:15 p.m. – 3:30 p.m. | Poster Hall – Exhibit Hall A | Screen 9
- Poster Session: PQA 06 - Genitourinary Cancer, Gynecological Cancer, and Health Care Access and Engagement
- Presentation: 3306 - Dosimetric Assessment of ¹77Lu-PSMA-617 and SBRT In Locally Advanced Prostate Cancer: Interim Dosimetry of the STARLiT Trial
Wednesday, September 30 | 9:30 a.m. – 9:35 a.m. | Room 157
- Session: QP 41 - Biologic Determinants of Radiation Response
- Presentation: 1243 - Radiation Enhances Efficacy of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer via HER2 Upregulation
Samuel Lichtman-Mikol, MD
Wednesday, September 30 | 9:30 a.m. – 9:35 a.m. | Room 157
- Poster Session: QP 46 - Imaging for Planning
- Presentation: 1273 - Prospective Evaluation of a C-Arm Based Advanced On-Board Cone-Beam Computed Tomography (CBCT) System for Treatment Planning Feasibility across Multiple Anatomic Sites
Janice Lyons, MD
Monday, September 28 | 1:40 p.m. – 1:44 p.m. | Grand Ballroom
Pranshu Mohindra, MD, MMM, FABS
Saturday, September 26 | 11:07 a.m. – 11:27 a.m. | Room 210
- Session: PRO 03 - Practical Management of NSCLC in the Immunotherapy Era
- Presentation: Optimal Management of Stage III NSCLC in the Chemoimmunotherapy Era
Tuesday, September 29 | 12:35 p.m. – 12:40 p.m. | Room 259
- Session: QP 19 - Research to Inform Healthcare Access Interventions in Radiation Oncology
- Presentation: 1109 - Pre-Treatment Diagnostic and Staging Efficiency in Patients with Non-Small Cell Lung Cancer (NSCLC): A Systems Operations Audit in an Integrated Health System
Tuesday, September 29 | 2:15 p.m. – 3:30 p.m. | Poster Hall – Exhibit Hall A | Screen 9
- Poster Session: PQA 06 - Genitourinary Cancer, Gynecological Cancer, and Health Care Access and Engagement
- Presentation: 3704 - Timeliness of In-Patient Radiation Therapy: An Informatics Care Pathway Interval Analysis of Hospital Length of Stay in an Integrated Health System
Haley Perlow, MD
Sunday, September 27 | 3:00 p.m. – 4:00 p.m. | Poster Hall – Exhibit Hall A | Screen 6
- Poster Session: PQA 01 - Gastrointestinal Cancer and Central Nervous System
- Presentation: 2174 - Baseline and Time Dependent Predictors of Worsened Quality of Life, Symptoms of Depression, Anxiety, and Self-Reported Cognition: A Secondary Analysis of the ATHENA Trial
Monday, September 28 | 8:00 a.m. – 9:00 a.m. | Room 254
- Session: QP 06 - Neurocognition and Novel Therapies in Glioma (moderator)
- Presentation: Neurocognition and Novel Therapies in Glioma
Soumyajit Roy, MD
Sunday, September 27 | 3:00 p.m. – 4:00 p.m. | Room 205- Scientific Session: SS 02 - Escalate, De-escalate, or Substitute? Trials Shaping Prostate Cancer Care (moderator)
- Presentation: Escalate, De-escalate, or Substitute? Trials Shaping Prostate Cancer Care
Sunday, September 27 | 4:00 p.m. – 5:00 p.m. | Poster Hall – Exhibit Hall A | Screen 12
- Poster Session: PQA 02 - Pediatric Cancer, Sarcoma and Cutaneous Tumors, Medical Education & Professional Development, and Health Services Research
- Presentation: 2373 - Integrating Gene Expression and Clinical Variables Improves Prediction of Disease Progression in Neuroblastoma: A Secondary Analysis of the SEQC Cohort
Monday, September 28 | 5:10 p.m. – 5:15 p.m. | Room 205
- Session: QP 22 - Refining Prostate Cancer Care: Integration, Innovation, and Outcomes
- Presentation: 1130 - Differential Association of Post-Testosterone Recovery PSA Kinetics with Progression and Metastatic Outcomes In Prostate Cancer
Tuesday, September 29 | 5:15 p.m. – 6:15 p.m. | Room 204
- QP 26 - The Right Patient, the Right Treatment: Machine Learning for Stratification and Prediction
- Moderator and Q&A
Daniel Spratt, MD
Tuesday, September 29 | 2:15 p.m. – 3:30 p.m. | Poster Hall – Exhibit Hall A | Screen 9
- Poster Session: PQA 06 - Genitourinary Cancer, Gynecological Cancer, and Health Care Access and Engagement
- Presentation: 3380 - Effectiveness and Safety of Relugolix in Patients With Advanced Prostate Cancer Receiving Radiation Therapy: 6-Month Subgroup Analysis of the OPTYX Study
Tuesday, September 29 | 2:15 p.m. – 3:30 p.m. | Poster Hall – Exhibit Hall A | Screen 9
- Poster Session: PQA 06 - Genitourinary Cancer, Gynecological Cancer, and Health Care Access and Engagement
- 3379 - Benchmarking Multimodal AI-Predicted Metastasis and Prostate Cancer-Specific Mortality Risk Against STAR-CAP: A 20,000-Patient Commercial Experience
Tuesday, September 29 | 4:17 p.m. – 4:32 p.m. | Room 205
- Education Session: EDU 47 - Precision in Practice: The Use of Novel Biomarkers in GU Cancers
- Roler of Biomarkers in the Post-operative setting for Prostate Cancer
Nan Zhao, MD, PhD
Tuesday, September 29 | 2:15 p.m. – 3:30 p.m. | Poster Hall – Exhibit Hall A | Screen 9